4//SEC Filing
Johnston John Joseph 4
Accession 0001415889-25-002263
CIK 0001287098other
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 4:13 PM ET
Size
9.2 KB
Accession
0001415889-25-002263
Insider Transaction Report
Form 4
MAXCYTE, INC.MXCT
Johnston John Joseph
Director
Transactions
- Exercise/Conversion
Common Stock
2025-01-27$2.93/sh+3,000$8,796→ 144,950 total - Sale
Common Stock
2025-01-27$4.64/sh−3,000$13,935→ 141,950 total - Exercise/Conversion
Stock Option (right to buy)
2025-01-27−3,000→ 17,417 totalExercise: $2.93Exp: 2028-07-18→ Common Stock (3,000 underlying)
Footnotes (3)
- [F1]The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023.
- [F2]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.52 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]This option is fully vested and exercisable.
Documents
Issuer
MAXCYTE, INC.
CIK 0001287098
Entity typeother
Related Parties
1- filerCIK 0001874850
Filing Metadata
- Form type
- 4
- Filed
- Jan 28, 7:00 PM ET
- Accepted
- Jan 29, 4:13 PM ET
- Size
- 9.2 KB